Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S7UU
|
|||
| Former ID |
DIB000384
|
|||
| Drug Name |
PF-06260414
|
|||
| Synonyms |
PF-14
Click to Show/Hide
|
|||
| Indication | Cachexia [ICD-11: MG20; ICD-10: R64; ICD-9: 799.4] | Discontinued in Phase 1 | [1] | |
| Pain [ICD-11: MG30-MG3Z] | Investigative | [2] | ||
| Company |
PharmacoFore Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H14N4O2S
|
|||
| Canonical SMILES |
CC1CNS(=O)(=O)N(C1)C2=CC3=C(C=C2)C(=NC=C3)C#N
|
|||
| InChI |
1S/C14H14N4O2S/c1-10-8-17-21(19,20)18(9-10)12-2-3-13-11(6-12)4-5-16-14(13)7-15/h2-6,10,17H,8-9H2,1H3/t10-/m1/s1
|
|||
| InChIKey |
ZKAVFOXYJCREBQ-SNVBAGLBSA-N
|
|||
| CAS Number |
CAS 1612755-71-1
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800040072) | |||
| REF 2 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
| REF 3 | Phase I clinical trail of PF-06260414 for treating cachexia. Pfizer Inc. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.